329 related articles for article (PubMed ID: 18700216)
1. Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia.
Swanson JW; Swartz MS; Van Dorn RA; Volavka J; Monahan J; Stroup TS; McEvoy JP; Wagner HR; Elbogen EB; Lieberman JA;
Br J Psychiatry; 2008 Jul; 193(1):37-43. PubMed ID: 18700216
[TBL] [Abstract][Full Text] [Related]
2. Impact of antipsychotic medication on family burden in schizophrenia: longitudinal results of CATIE trial.
Perlick DA; Rosenheck RA; Kaczynski R; Swartz MS; Canive JM; Lieberman JA
Schizophr Res; 2010 Feb; 116(2-3):118-25. PubMed ID: 19864114
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
Stroup TS; Lieberman JA; McEvoy JP; Swartz MS; Davis SM; Capuano GA; Rosenheck RA; Keefe RS; Miller AL; Belz I; Hsiao JK;
Am J Psychiatry; 2007 Mar; 164(3):415-27. PubMed ID: 17329466
[TBL] [Abstract][Full Text] [Related]
4. The CATIE and CUtLASS studies in schizophrenia: results and implications for clinicians.
Naber D; Lambert M
CNS Drugs; 2009 Aug; 23(8):649-59. PubMed ID: 19594194
[TBL] [Abstract][Full Text] [Related]
5. Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: evidence from the CATIE study.
Levine SZ; Rabinowitz J; Ascher-Svanum H; Faries DE; Lawson AH
Schizophr Res; 2011 Dec; 133(1-3):42-6. PubMed ID: 22000938
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
Lieberman JA; Stroup TS; McEvoy JP; Swartz MS; Rosenheck RA; Perkins DO; Keefe RS; Davis SM; Davis CE; Lebowitz BD; Severe J; Hsiao JK;
N Engl J Med; 2005 Sep; 353(12):1209-23. PubMed ID: 16172203
[TBL] [Abstract][Full Text] [Related]
7. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
Keefe RS; Bilder RM; Davis SM; Harvey PD; Palmer BW; Gold JM; Meltzer HY; Green MF; Capuano G; Stroup TS; McEvoy JP; Swartz MS; Rosenheck RA; Perkins DO; Davis CE; Hsiao JK; Lieberman JA; ;
Arch Gen Psychiatry; 2007 Jun; 64(6):633-47. PubMed ID: 17548746
[TBL] [Abstract][Full Text] [Related]
8. Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial.
Gharabawi GM; Greenspan A; Rupnow MF; Kosik-Gonzalez C; Bossie CA; Zhu Y; Kalali AH; Awad AG
BMC Psychiatry; 2006 Oct; 6():45. PubMed ID: 17054789
[TBL] [Abstract][Full Text] [Related]
9. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
10. What CATIE found: results from the schizophrenia trial.
Swartz MS; Stroup TS; McEvoy JP; Davis SM; Rosenheck RA; Keefe RS; Hsiao JK; Lieberman JA
Psychiatr Serv; 2008 May; 59(5):500-6. PubMed ID: 18451005
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study.
Swartz MS; Wagner HR; Swanson JW; Stroup TS; McEvoy JP; Reimherr F; Miller DD; McGee M; Khan A; Canive JM; Davis SM; Hsiao JK; Lieberman JA;
Schizophr Res; 2008 Mar; 100(1-3):39-52. PubMed ID: 18191383
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia.
Rosenheck RA; Leslie DL; Sindelar J; Miller EA; Lin H; Stroup TS; McEvoy J; Davis SM; Keefe RS; Swartz M; Perkins DO; Hsiao JK; Lieberman J;
Am J Psychiatry; 2006 Dec; 163(12):2080-9. PubMed ID: 17151158
[TBL] [Abstract][Full Text] [Related]
13. Effect of antipsychotic medication on overall life satisfaction among individuals with chronic schizophrenia: findings from the NIMH CATIE study.
Fervaha G; Agid O; Takeuchi H; Foussias G; Remington G
Eur Neuropsychopharmacol; 2014 Jul; 24(7):1078-85. PubMed ID: 24726579
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of atypical antipsychotic medications in reducing violent behavior among persons with schizophrenia in community-based treatment.
Swanson JW; Swartz MS; Elbogen EB
Schizophr Bull; 2004; 30(1):3-20. PubMed ID: 15176758
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of switching antipsychotic medications.
Essock SM; Covell NH; Davis SM; Stroup TS; Rosenheck RA; Lieberman JA
Am J Psychiatry; 2006 Dec; 163(12):2090-5. PubMed ID: 17151159
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
[TBL] [Abstract][Full Text] [Related]
17. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
[TBL] [Abstract][Full Text] [Related]
18. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care.
Ascher-Svanum H; Faries DE; Zhu B; Ernst FR; Swartz MS; Swanson JW
J Clin Psychiatry; 2006 Mar; 67(3):453-60. PubMed ID: 16649833
[TBL] [Abstract][Full Text] [Related]
19. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode.
Perkins DO; Johnson JL; Hamer RM; Zipursky RB; Keefe RS; Centorrhino F; Green AI; Glick IB; Kahn RS; Sharma T; Tohen M; McEvoy JP; Weiden PJ; Lieberman JA;
Schizophr Res; 2006 Mar; 83(1):53-63. PubMed ID: 16529910
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge.
Marcus SC; Zummo J; Pettit AR; Stoddard J; Doshi JA
J Manag Care Spec Pharm; 2015 Sep; 21(9):754-68. PubMed ID: 26308223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
